These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9747464

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Mutations in human O6-alkylguanine-DNA alkyltransferase imparting resistance to O6-benzylguanine.
    Crone TM, Goodtzova K, Edara S, Pegg AE.
    Cancer Res; 1994 Dec 01; 54(23):6221-7. PubMed ID: 7954470
    [Abstract] [Full Text] [Related]

  • 44. Genetic modification of haematopoietic cells for combined resistance to podophyllotoxins, other agents covered by MDR1-mediated efflux activity and nitrosoureas.
    Baum C, Peinert S, Carpinteiro A, Eckert HG, Fairbairn LJ.
    Bone Marrow Transplant; 2000 May 01; 25 Suppl 2():S71-4. PubMed ID: 10933194
    [Abstract] [Full Text] [Related]

  • 45. Long-term protection of hematopoiesis against the cytotoxic effects of multiple doses of nitrosourea by retrovirus-mediated expression of human O6-alkylguanine-DNA-alkyltransferase.
    Jelínek J, Fairbairn LJ, Dexter TM, Rafferty JA, Stocking C, Ostertag W, Margison GP.
    Blood; 1996 Mar 01; 87(5):1957-61. PubMed ID: 8634444
    [Abstract] [Full Text] [Related]

  • 46. Genetic chemoprotection with mutant O6-alkylguanine-DNA-alkyltransferases.
    Hobin DA, Fairbairn LJ.
    Curr Gene Ther; 2002 Feb 01; 2(1):1-8. PubMed ID: 12108970
    [Abstract] [Full Text] [Related]

  • 47. Role of O6-alkylguanine-DNA alkyltransferase in the resistance of mouse spermatogenic cells to O6-alkylating agents.
    Thompson MJ, Abdul-Rahman S, Baker TG, Rafferty JA, Margison GP, Bibby MC.
    J Reprod Fertil; 2000 Jul 01; 119(2):339-46. PubMed ID: 10864847
    [Abstract] [Full Text] [Related]

  • 48. Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells.
    Allay JA, Dumenco LL, Koc ON, Liu L, Gerson SL.
    Blood; 1995 Jun 01; 85(11):3342-51. PubMed ID: 7756667
    [Abstract] [Full Text] [Related]

  • 49. Engineering drug resistance in human cells.
    Fairbairn LJ, Rafferty JA, Lashford LS.
    Bone Marrow Transplant; 2000 May 01; 25 Suppl 2():S110-3. PubMed ID: 10933202
    [Abstract] [Full Text] [Related]

  • 50. Retroviral transfer of a bacterial alkyltransferase gene (ada) into human bone marrow cells protects against O6-benzylguanine plus 1, 3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity.
    Marathi UK, Harris LC, Venable CC, Brent TP.
    Clin Cancer Res; 1997 Feb 01; 3(2):301-7. PubMed ID: 9815687
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Investigation of the role of tyrosine-114 in the activity of human O6-alkylguanine-DNA alkyltranferase.
    Goodtzova K, Kanugula S, Edara S, Pegg AE.
    Biochemistry; 1998 Sep 08; 37(36):12489-95. PubMed ID: 9730821
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Differential sensitivity of human and mouse alkyltransferase to O6-benzylguanine using a transgenic model.
    Liu L, Lee K, Wasan E, Gerson SL.
    Cancer Res; 1996 Apr 15; 56(8):1880-5. PubMed ID: 8620508
    [Abstract] [Full Text] [Related]

  • 57. Increasing DNA repair capacity in bone marrow by gene transfer as a prospective tool in cancer therapy.
    Kleibl K, Margison GP.
    Neoplasma; 1998 Apr 15; 45(4):181-6. PubMed ID: 9890659
    [Abstract] [Full Text] [Related]

  • 58. Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide.
    Tentori L, Orlando L, Lacal PM, Benincasa E, Faraoni I, Bonmassar E, D'Atri S, Graziani G.
    Mol Pharmacol; 1997 Aug 15; 52(2):249-58. PubMed ID: 9271347
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.